If you need more lookups,
subscriptions start at $34 USD/month.
Ke Yu Location
San Diego, CA, US
Ke Yu Work
Sr. Director of DMPK @ (June 2024 - Present)
Director of DMPK @ (July 2023 - June 2024)
Associate Director of DMPK @ (August 2022 - July 2023)
Principal Scientist @ (January 2022 - August 2022)
Senior Scientist @ (August 2019 - December 2021)
Senior Scientist in DMPK @ (January 2019 - August 2019)
DMPK Scientist II @ (January 2017 - December 2018)
DMPK Scientist I @ (August 2015 - December 2016)
Research Scholar @ (April 2012 - August 2015)
Associate Professor @ Center for DMPK Research, Shanghai Institute of Materia Medica, Chinese Academy (September 2009 - February 2012)
Assistant Professor @ Center for DMPK Research, Shanghai Institute of Materia Medica, Chinese Academy (July 2007 - September 2009)
Ke Yu Education
Zhejiang University
Ph.D. (Pharmaceutical Science)
2002-2007
Zhejiang University
Bachelor's degree (Pharmaceutical Engineering)
1998-2002
Ke Yu Skills
PK modeling and simulation
Human dose projection
Human PK prediction
PK/PD modeling
DDI risk assessment
Pharmacokinetics
Drug metabolism
DMPK
Drug Safety
Bioanalysis
HPLC-MS
GraphPad Prism
Bioinformatics
R
Matlab
Animal Models
Life Sciences
Drug Discovery
Science
Biochemistry
In Vivo
Liquid Chromatography-Mass Spectrometry (LC-MS)
Teaching
Management
Hplc Ms
Chemistry
Liquid Chromatography Mass Spectrometry Lc Ms
Liquid Chromatography Mass Spectrometry
Ke Yu Summary
Ke Yu, based in San Diego, CA, US, is currently a Sr. Director of DMPK at Alterome Therapeutics, Inc. Ke Yu brings experience from previous roles at Alterome Therapeutics, Inc, Gossamer Bio and Kumquat Biosciences Inc.. Ke Yu holds a 2002 - 2007 Ph.D. in Pharmaceutical Science @ Zhejiang University. With a robust skill set that includes PK modeling and simulation, Human dose projection, Human PK prediction, PK/PD modeling, DDI risk assessment and more. Ke Yu has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Ke Yu?
Find contact details for 700 million professionals.